Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 29, 16 January 2024
Open
Access | Article
Gut-to-brain axis provides novel therapeutic targets for depression
* Author to whom correspondence should be addressed.
Abstract
As an essential counterpart of the human internal environment, the gut microbiome has been investigated extensively in light of multiple diseases. This study aims to find out potential treatments for depression by altering gut microbiome composition in order to alleviate side effects caused by traditional medications. According to previous findings, the human gut correlates with the brain through pathways known as the gut-brain axis. Two genera of microbiome, Lactobacillus and Bifidobacterium, have been mentioned by researchers to be crucial to depression-related neurotransmitter secretion in GBA. Besides, they have already been used in clinical as effective probiotics for gut-related diseases. The paper hypothesized particular interactions between the two genera and the human nerve that enable them to be therapeutic cures in adequate amounts. In this study, a range of available single-cell data about “depression” and “lactobacillus and bifidobacterium” were analyzed and adjusted into proper figures. I discuss the efficacy of different species, concentrations, and other elements of those probiotics, eventually proposing a novel way of treating and classifying depressive disorders. The study puts forth a perspective of maintaining a depression-free state with an internal factor, the gut microbiome, instead of targeting the efferent neurons directly with external drugs which could cause resistance and severe side effects.
Keywords
Microbiome, Depression, Lactobacillus, Bifidobacterium, probiotics, Gut-Brain Axis
References
1. Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, J. L., Vos, T., & Whiteford, H. A. (2013). Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010. PLoS Medicine, 10(11). https://doi.org/10.1371/journal.pmed.1001547
2. Abeysekera, N. W. B. Y., & De Zoysa, E. (2021). Higher prevalence of geriatric depression, catastrophizing pain and sleep disorders in institutionalized elders: a cross-sectional study in Galle District, Sri Lanka. BMC geriatrics, 21(1), 685. https://doi.org/10.1186/s12877-021-02536-9
3. Shorey, S., Ng, E. D., & Wong, C. H. J. (2022). Global prevalence of depression and elevated depressive symptoms among adolescents: A systematic review and meta-analysis. The British journal of clinical psychology, 61(2), 287–305. https://doi.org/10.1111/bjc.12333
4. Ettman CK, Abdalla SM, Cohen GH, Sampson L, Vivier PM, Galea S. Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic. JAMA Netw Open. 2020;3(9):e2019686. doi:10.1001/jamanetworkopen.2020.19686
5. Hirschfeld R. M. (2000). History and evolution of the monoamine hypothesis of depression. The Journal of clinical psychiatry, 61 Suppl 6, 4–6. https://www.psychiatrist.com/jcp/depression/history-evolution-monoamine-hypothesis-depression/
6. Micheli, L., Ceccarelli, M., D’Andrea, G., & Tirone, F. (2018). Depression and adult neurogenesis: Positive effects of the antidepressant fluoxetine and of physical exercise. Brain research bulletin, 143, 181–193. https://doi.org/10.1016/j.brainresbull.2018.09.002
7. Demyttenaere, K., & Jaspers, L. (2008). Review: Bupropion and SSRI-induced side effects. Journal of psychopharmacology (Oxford, England), 22(7), 792–804. https://doi.org/10.1177/0269881107083798
8. Murrough, J. W., Yaqubi, S., Sayed, S., & Charney, D. S. (2015). Emerging drugs for the treatment of anxiety. Expert opinion on emerging drugs, 20(3), 393–406.
9. Altaf, R., Gonzalez, I., Rubino, K., & Nemec, E. C., 2nd (2021). Folate as adjunct therapy to SSRI/SNRI for major depressive disorder: Systematic review & meta-analysis. Complementary therapies in medicine, 61, 102770.
10. Rhee, S. H., Pothoulakis, C., & Mayer, E. A. (2009). Principles and clinical implications of the brain-gut-enteric microbiota axis. Nature reviews. Gastroenterology & hepatology, 6(5), 306–314. https://doi.org/10.1038/nrgastro.2009.35
11. Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the National Academy of Sciences of the United States of America, 108(38), 16050–16055. https://doi.org/10.1073/pnas.1102999108
12. Fujimura, K. E., Slusher, N. A., Cabana, M. D., & Lynch, S. V. (2010). Role of the gut microbiota in defining human health. Expert review of anti-infective therapy, 8(4), 435–454. https://doi.org/10.1586/eri.10.14
13. Kelly, J. R., Borre, Y., O’ Brien, C., Patterson, E., El Aidy, S., Deane, J., Kennedy, P. J., Beers, S., Scott, K., Moloney, G., Hoban, A. E., Scott, L., Fitzgerald, P., Ross, P., Stanton, C., Clarke, G., Cryan, J. F., & Dinan, T. G. (2016). Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat. Journal of Psychiatric Research, 82, 109-118. https://doi.org/10.1016/j.jpsychires.2016.07.019
14. Burns, C. (2022). Antidepressant prescribing increases by 35% in six years. The Pharmaceutical Journal, PJ, Vol 309, 7963;309(7963). doi:10.1211/PJ.2022.1.149158
15. Li, S. C., Hsu, W. F., Chang, J. S., & Shih, C. K. (2019). Combination of Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis Shows a Stronger Anti-Inflammatory Effect than Individual Strains in HT-29 Cells. Nutrients, 11(5), 969. https://doi.org/10.3390/nu11050969
16. Liu, L., Wang, H., Chen, X., Zhang, Y., Zhang, H., & Xie, P. (2023). Gut microbiota and its metabolites in depression: from pathogenesis to treatment. EBioMedicine, 90, 104527. https://doi.org/10.1016/j.ebiom.2023.104527
17. Liu, L., Wang, H., Zhang, H., Chen, X., Zhang, Y., Wu, J., Zhao, L., Wang, D., Pu, J., Ji, P., & Xie, P. (2022). Toward a Deeper Understanding of Gut Microbiome in Depression: The Promise of Clinical Applicability. Advanced science (Weinheim, Baden-Wurttemberg,Germany), 9(35), e2203707. https://doi.org/10.1002/advs.202203707
18. Radjabzadeh, D., Bosch, J. A., Uitterlinden, A. G., Zwinderman, A. H., Ikram, M. A., Van Meurs, J. B., Luik, A. I., Nieuwdorp, M., Lok, A., Van Duijn, C. M., Kraaij, R., & Amin, N. (2022). Gut microbiome-wide association study of depressive symptoms. Nature Communications, 13(1), 1-10. https://doi.org/10.1038/s41467-022-34502-3
19. O’Callaghan, J., & O’Toole, P. W. (2013). Lactobacillus: host-microbe relationships. Current topics in microbiology and immunology, 358, 119–154. https://doi.org/10.1007/82_2011_187
20. Chen, J. J., Zheng, P., Liu, Y. Y., Zhong, X. G., Wang, H. Y., Guo, Y. J., & Xie, P. (2018). Sex differences in gut microbiota in patients with major depressive disorder. Neuropsychiatric disease and treatment, 14, 647–655. https://doi.org/10.2147/NDT.S159322
21. Emiko Aizawa, Hirokazu Tsuji, Takashi Asahara, Takuya Takahashi, Toshiya Teraishi, Sumiko Yoshida, Miho Ota, Norie Koga, Kotaro Hattori, Hiroshi Kunugi. Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder, Journal of Affective Disorders, Volume 202, 2016, Pages 254-257, ISSN 0165-0327,https://doi.org/10.1016/j.jad.2016.05.038.
22. Marco, M. L., Pavan, S., & Kleerebezem, M. (2006). Towards understanding molecular modes of probiotic action. Current opinion in biotechnology, 17(2), 204–210. https://doi.org/10.1016/j.copbio.2006.02.005
23. Wynendaele, E., Verbeke, F., Stalmans, S., Gevaert, B., Janssens, Y., Van De Wiele, C., et.al. (2015). Quorum Sensing Peptides Selectively Penetrate the Blood-Brain Barrier. PloS one, 10 (11), e0142071.
24. Medina-Rodriguez, E. M., Madorma, D., O’Connor, G., Mason, B. L., Han, D., Deo, S. K., et.al. (2020). Identification of a Signaling Mechanism by Which the Microbiome Regulates Th17 Cell-Mediated Depressive-Like Behaviors in Mice. The American journal of psychiatry, 177 (10), 974–990.
25. Duranti, S., Ruiz, L., Lugli, G. A., Tames, H., Milani, C., Mancabelli, L., Mancino, W., Longhi, G., Carnevali, L., Sgoifo, A., Margolles, A., Ventura, M., Ruas-Madiedo, P., & Turroni, F. (2020). Bifidobacterium adolescentis as a key member of the human gut microbiota in the production of GABA. Scientific reports, 10(1), 14112. https://doi.org/10.1038/s41598-020-70986-z
26. Luo, J., Li, Y., Xie, J., Gao, L., Liu, L., Ou, S., Chen, L., & Peng, X. (2018). The primary biological network of Bifidobacterium in the gut. FEMS Microbiology Letters, 365(8). https://doi.org/10.1093/femsle/fny057
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 2nd International Conference on Modern Medicine and Global Health
- ISBN (Print)
- 978-1-83558-279-4
- ISBN (Online)
- 978-1-83558-280-0
- Published Date
- 16 January 2024
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/29/20240754
- Copyright
- 16 January 2024
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited